Aktiv-Dry LLC, founded in 2002, provides dry powder processing solutions for the vaccine, pharmaceutical, and biotechnology industries. In addition to its research involving an inhalable measles vaccine, Aktiv-Dry is also involved in research on an inhalable vaccine to help stop smoking and on a project to decrease the body's adsorption of cholesterol that is ingested from food.